<DOC>
	<DOC>NCT02106468</DOC>
	<brief_summary>This study was initiated to evaluate the potential of dietary supplementation of omega-3 for providing an inexpensive, safe and effective therapeutic agent for managing atrophic/erosive lichen planus.</brief_summary>
	<brief_title>The Efficacy of Omega-3 in Treatment of Atrophic/Erosive Lichen Planus</brief_title>
	<detailed_description />
	<mesh_term>Lichen Planus, Oral</mesh_term>
	<mesh_term>Lichen Planus</mesh_term>
	<mesh_term>Prednisone</mesh_term>
	<criteria>1. Clinical diagnosis of OLP (Presence of painful and atrophicerosive oral Lesions, bilateral, mostly symmetrical lesions, presence of lacelike network of slightly raised white lines). 2. Age between 3060 years 3. Ability to complete the present clinical trial. 1. Pregnant or breast feeding women (pregnancy test for women of child bearing age). 2. Lichenoid reactions caused by certain drugs or dental amalgam. 3. Therapy for oral lichen planus (OLP) in the 6 months prior to the study. 4. Patient doesn't have hepatitis C [after the patients' medical histories were recorded, the patients were given hepatic screening as published elsewhere. 2 5. Presence of candidiasis before treatment. 6. Patients with preexisting diabetes or an initial random glucose level exceeding 200 mg/dL before initiating steroid therapy were excluded. 7. Hypertensive patients 8. Contraindications for corticosteroid use (immunodeficiency or severe heamatological alterations).</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>March 2014</verification_date>
	<keyword>Oral Lichen Planus</keyword>
	<keyword>Corticosteroid</keyword>
	<keyword>Omega -3</keyword>
</DOC>